Alex Azar, former president, Lilly USA & former Deputy Secretary, U.S. Department of Health sits down with Matt Wallach to discuss the major trends impacting the life sciences industry. Listen to these industry leaders talk about why the death of the pharma sales rep is greatly exaggerated, the pivot to key account management, and the impact of digital disruption.

Learn more about the Digital Accelerator series.